Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-206"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20101124.15.3-206"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"I voted in favour of this report as I am particularly interested in health-related topics, especially concerning equal access for patients to medical care and information. At the moment, the level of information about the medicines available on the market varies hugely in Europe, which I could say is even unfair to patients. Patients must have the right to obtain complete, correct information about medicines. The proposals from my colleague Christofer Fjellner have gone precisely in this direction, thereby giving priority to the patient. The amendments made by the European Parliament to the European Commission’s legislative proposal highlight that manufacturers of medicinal products must provide basic information such as product characteristics, a label, patient information leaflet and a publicly available version of the assessment report. However, so that we can ensure that the information is reliable, I think that national authorities must monitor stringently the specialist sites which supply such details."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples